Possible involvement of GLP-1(9-36) in the regional haemodynamic effects of GLP-1(7-36) in conscious rats.
about
Cardiovascular and hemodynamic effects of glucagon-like peptide-1.Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetesCardiovascular benefits of GLP-1-based herapies in patients with diabetes mellitus type 2: effects on endothelial and vascular dysfunction beyond glycemic control.Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndromeCardiovascular Benefits of Native GLP-1 and its Metabolites: An Indicator for GLP-1-Therapy Strategies.Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.Glucagon-like peptide-1 and its cardiovascular effects.Renal and cardiac effects of DPP4 inhibitors--from preclinical development to clinical research.Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus.Cardiovascular responses to retigabine in conscious rats--under normotensive and hypertensive conditionsIdentification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model.Exendin-4 ameliorates cardiac ischemia/reperfusion injury via caveolae and caveolins-3.Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats.Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetes.Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flowDissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
P2860
Q33993725-7A93D0D1-76D1-4A20-9ADA-8033F5EC1D02Q34994502-38449369-E957-48B7-9645-C760D23D3449Q35936644-FF52B7E6-410A-4B7D-A0D7-248663F4687AQ36629691-2D4CD7AC-A777-48DB-BF4A-BBEC07CAFD2DQ37611715-1AB1EAC7-60F1-4CB9-827F-7C4B523B7BC2Q37825946-D27FEB70-D2AC-4D4F-8A9E-D89C06FA985DQ38033468-E505382B-F742-4F1A-8EB4-83D28B63875CQ38040596-6A88E1CC-05C9-4660-B62E-7FB756B4845BQ38148574-0ED45FC6-DFA5-4472-B15A-45012282560CQ41771260-1A22366F-06D4-424F-BF77-45045C253B36Q41826601-72253882-FCE6-4244-83F6-36F908EFC5C2Q41852482-FA18C532-BC64-4351-AD09-90DE9D86AA41Q42323403-4C97B20C-196F-4991-90B1-2460B24874D4Q53215510-259F49D7-8F17-4C6B-9D95-65039199CF76Q58447525-B3A3FA42-3611-45B0-BE4E-5E9FB9E7412CQ58572799-73E00B9F-82B9-4587-9027-9D06F92F512C
P2860
Possible involvement of GLP-1(9-36) in the regional haemodynamic effects of GLP-1(7-36) in conscious rats.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Possible involvement of GLP-1( ...... GLP-1(7-36) in conscious rats.
@en
type
label
Possible involvement of GLP-1( ...... GLP-1(7-36) in conscious rats.
@en
prefLabel
Possible involvement of GLP-1( ...... GLP-1(7-36) in conscious rats.
@en
P2093
P2860
P1476
Possible involvement of GLP-1( ...... GLP-1(7-36) in conscious rats.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.2010.00867.X
P407
P577
2010-09-01T00:00:00Z